Clinical trial / 2016
Roselle calyx powder significantly decreased systolic blood pressure and serum triglycerides in adults with metabolic syndrome.
Forty adults with metabolic syndrome were randomly assigned to receive either 500 mg of Hibiscus sabdariffa calyx powder or placebo once daily for 4 weeks. Compared to placebo, H. sabdariffa significantly reduced serum triglycerides (p=0.044) and systolic blood pressure (p=0.049). All other measured variables—including diastolic blood pressure, BMI, fasting plasma glucose, insulin, lipoproteins, hs-CRP, and malondialdehyde—were not significantly affected.
- Study type
- Double-blind placebo-controlled randomized trial
- Who was studied
- 40 adult patients with metabolic syndrome
- What was measured
- Blood pressure, BMI, fasting glucose, insulin, lipids/TG, hs-CRP, and MDA
THE PAPER
Evaluation of the effects of roselle (Hibiscus sabdariffa L.) on oxidative stress and serum levels of lipids, insulin and hs-CRP in adult patients with metabolic syndrome: a double-blind placebo-controlled clinical trial.
Asgary S, Soltani R, Zolghadr M, Keshvari M, Sarrafzadegan N. J Complement Integr Med, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.